Publications by authors named "Matthieu Blanchet"

Claim this Profile
E
Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes.
Marwa Khabir, Matthieu Blanchet, Léna Angelo, Hamza Loucif, Julien van Grevenynghe

Viruses· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression.
Matthieu Blanchet, Léna Angelo, Yasmine Tétreault, Marwa Khabir, Camille Sureau

Viruses· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.
Léna Angelo, Andrew Vaillant, Matthieu Blanchet, Patrick Labonté

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.
Richard Boulon, Matthieu Blanchet, Matthieu Lemasson, Andrew Vaillant, Patrick Labonté

Antiviral Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
Marwa Khabir, Asma Zahra Aliche, Camille Sureau, Matthieu Blanchet, Patrick Labonté

J Virol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.
Matthieu Blanchet, Vigigah Sinnathamby, Andrew Vaillant, Patrick Labonté

Antiviral Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.
Ahmed M Fahmy, Marwa Khabir, Matthieu Blanchet, Patrick Labonté

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection .
Frauke Beilstein, Matthieu Blanchet, Andrew Vaillant, Camille Sureau

J Virol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
Clément Guillot, Nora Martel, Françoise Berby, Isabelle Bordes, Olivier Hantz, Matthieu Blanchet

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response relationships in gene expression profiles in a harbor seal B lymphoma cell line exposed to 17 -ethinyl estradiol.
Christine Kleinert, Matthieu Blanchet, François Gagné, Michel Fournier

J Xenobiot· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins can exert dual, concentration dependent effects on HCV entry in vitro.
Matthieu Blanchet, Quoc-Tuan Le, Nabil G Seidah, Patrick Labonté

Antiviral Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.
Quoc-Tuan Le, Matthieu Blanchet, Nabil G Seidah, Patrick Labonté

J Biol Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.
Matthieu Blanchet, Camille Sureau, Carl Guévin, Nabil G Seidah, Patrick Labonté

Antiviral Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.
Matthieu Blanchet, Camille Sureau, Patrick Labonté

Antiviral Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
Matthieu Blanchet, Nabil G Seidah, Patrick Labonté

Antiviral Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent.
Yann Le Duff, Matthieu Blanchet, Camille Sureau

J Virol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.
Matthieu Blanchet, Camille Sureau

J Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Matthieu Blanchet, Camille Sureau

J Virol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis